Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"

× No keyword cloud information.

4 in total

1. Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?

Authors: Samuel L Aitken; Farnaz Foolad; Patrick M McDaneld
Journal: Antimicrob Agents Chemother Date: 2017-08-24 Impact factor: 5.191

2. Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae.

Authors: Lucy Cheng; Brian C Nelson; Monica Mehta; Nikhil Seval; Sarah Park; Marla J Giddins; Qiuhu Shi; Susan Whittier; Angela Gomez-Simmonds; Anne-Catrin Uhlemann
Journal: Antimicrob Agents Chemother Date: 2017-05-24 Impact factor: 5.191

Review 3. Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.

Authors: Patrick N A Harris; Jane Y Wei; Andrew W Shen; Ahmed A Abdile; Stuart Paynter; Rachel R Huxley; Nirmala Pandeya; Yohei Doi; Kyungmin Huh; Catherine S O'Neal; Thomas R Talbot; David L Paterson
Journal: J Antimicrob Chemother Date: 2015-11-04 Impact factor: 5.790

4. Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study.

Authors: Patrick N A Harris; Anna M Peri; Anita M Pelecanos; Carly M Hughes; David L Paterson; John K Ferguson
Journal: Antimicrob Resist Infect Control Date: 2017-01-21 Impact factor: 4.887

4 in total